Sionna Therapeutics, Inc.·4

Jan 6, 4:24 PM ET

Fitzpatrick Jennifer 4

4 · Sionna Therapeutics, Inc. · Filed Jan 6, 2026

Insider Transaction Report

Form 4
Period: 2026-01-02
Fitzpatrick Jennifer
Chief Legal Officer
Transactions
  • Award

    Non-Qualified Stock Option (right to buy)

    2026-01-02+103,140103,140 total
    Exercise: $39.21Exp: 2036-01-01Common Stock (103,140 underlying)
Footnotes (1)
  • [F1]The shares underlying this option vest in forty-eight equal monthly installments following January 2, 2026, subject to the Reporting Person's continued service on each such vesting date.

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT